ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744683 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744683; 2) Community: the network communities that were significantly associated with the response to NSC 744683; 3) Molecule: the relationships between components within communities and NSC 744683; 4) MDR: the compounds that were significantly associated with the NSC 744683.

NSC Compound Enrichment Correlation
NSC 694488 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 3-(acetoxymethyl)- 0.0284896579188832 0.02035692
NSC 698955 Null 0.0284896579188832 -0.12090746
NSC 729527 Null 0.0284896579188832 0.18298468
NSC 729838 3-{(2E)-3-[4-(1H-benzimidazol-2-yl)phenyl]triaz-2-enyl}propa n-1-ol 0.0284896579188832 0.13367431
NSC 732179 Null 0.0284896579188832 0.13241666
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0285477013888565 0.27597056
NSC 267713 Digitoxigenin glycoside 0.0285477013888565 -0.049749177
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0285477013888565 0.19679611
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0285477013888565 0.1404781
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0285477013888565 0.16029314
Total:57  Current:33    [First] [Prev] [Next] [Last]